Melanoma Institute Australia   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Wollstonecraft Australia (1982)

Organization Overview

First Clinical Trial
2007
NCT00521053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Melanoma Institute Australia | Sydney Melanoma Unit

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Hutchinson's Melanotic Freckle (Phase 3)

Lentigo (Phase 3)

Melanoma (Phase 4)

Neoplasm Metastasis (Phase 2)

Neoplasms, Second Primary (Phase 2)

Skin Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 12